- WaveClear looks to start clinical trials for heart valve decalcification (read more)
- WaveClear participated in the LSI 2023 Emerging Medtech Summit (read more)
- WaveClear CEO Jeffrey Vaitekunas has been invited to participate in Ben Franklin Technology PArtners' "5 Minutes with Ben" radio series (Listen Here)
- Hunniwell Lake Ventures leads $1.125 million series A funding for WaveClear's technology (read more)
- WaveClear has been selected to participate in the MedTech Innovator 2021 Accelerator Cohort (read more)
-
Our Mission
WaveClear VascularTM medical device services were established to meet the need for treatment technologies to combat vascular diseases.Learn more
-
Our Technology
We utilize the piezoelectric effect to generate ultrasonic energy in wires. The wire tapers at key locations so that longitudinal waves traveling down its length will increase in amplitude and, near the end of the wire, convert the longitudinal waves into transverse waves.Learn more
-
Our Focus
WaveClear Vascular services particularly specialize in medical device design, research, and development, focusing on markets for ultrasonic therapeutic devices for the treatment of occlusive vasculature.Learn more